Biktarvy - Antiretroviral Therapy for FeLV & FIV
- Low stock - 7 items left
- Worldwide Shipping
- Fast Delivery (In 8-15 Days)
- 14-Days Money Back
- Secure Checkout
Pairs well with
Advanced Antiretroviral Support for Cats with FeLV & FIV
A diagnosis of Feline Leukaemia Virus (FeLV) or Feline Immunodeficiency Virus (FIV) doesn't have to mean giving up hope. Biktarvy (Bictegravir / Emtricitabine / Tenofovir Alafenamide) is a veterinary-compounded antiretroviral therapy increasingly used by feline specialists to suppress viral replication, protect immune function, and give your cat more quality time.
How Biktarvy Works
Biktarvy combines three complementary antiretroviral agents that target different stages of the viral replication cycle:
- Bictegravir (10 mg) — an integrase strand transfer inhibitor (INSTI) that blocks the virus from integrating into the host cell's DNA
- Emtricitabine (40 mg) — a nucleoside reverse transcriptase inhibitor (NRTI) that disrupts viral RNA replication
- Tenofovir Alafenamide (5 mg) — a prodrug NRTI that delivers targeted antiviral activity with a favorable safety profile
Together, this triple-combination approach creates a powerful barrier against viral replication, helping to preserve and restore your cat's immune system.
Why Choose Biktarvy for Your Cat?
- Triple-action antiretroviral formula — targets multiple stages of viral replication for comprehensive suppression
- Supports immune restoration — helps slow immune decline associated with FeLV and FIV progression
- Veterinary-compounded for feline use — specially formulated in small, palatable, or crushable tablets for easy administration
- Specialist-endorsed off-label therapy — increasingly adopted by feline medicine specialists for retroviral management
Product Details
- Active Ingredients: Bictegravir 10 mg + Emtricitabine 40 mg + Tenofovir Alafenamide 5 mg per tablet
- Formulation: Oral tablets (small, palatable, or crushable)
- Pack Size: 30 tablets
- Indication: Off-label management of FeLV and FIV in cats
Recommended Use
Biktarvy is an off-label, veterinary-prescribed therapy. Treatment protocols, dosing, and duration must be determined by a veterinarian experienced in feline infectious disease or internal medicine. Regular monitoring of viral load and immune markers is recommended throughout treatment.